期刊文献+

肿瘤基因启动子区异常甲基化与肿瘤的发生 被引量:2

Aberrant methylation of tumor gene promoter and tumorigenesis
下载PDF
导出
摘要 肿瘤的发生和发展是一个与多基因、多步骤的致癌因素相关的复杂过程,包括了原癌基因及肿瘤抑制基因的改变、错配修复基因的突变、DNA甲基化和微卫星不稳定性。癌基因的低甲基化与抑癌基因的高甲基化在肿瘤发生、发展中的基因表达调控、基因结构的稳定等方面发挥重要作用。DNA甲基化是指生物体在DNA甲基转移酶的催化下,以S-腺苷甲硫氨酸(SAM)为甲基供体,将甲基转移到特定碱基上的过程。甲基化异常被认为是肿瘤的一个特征,是基因组中一种重要的表观遗传修饰,与肿瘤的发生、浸润及转移相关。基因局部甲基化模式的改变已成为令人瞩目的研究领域。本文就DNA甲基化及肿瘤基因启动子区甲基化研究的相关进展作简要综述。 Tumorigenesis and development is a complex process which relates to multi-gene, multi- step carcinogenic factors, includeing the proto-oncogene and tumor suppressor gene alterations, mutations in mismatch repair genes, DNA methylation and microsatellite instability. Oncogene hypomethylation and hypermethylation of tumor suppressor genes play an important role in tumor development, the regulation of gene expression, gene structure stability. DNA methylation is a process of methyl, which S-adenosyl methionine (SAM) as a methyl donor, transferred to the specific base under the catalysis of DNA methyltransferase. Methylation abnormality is considered to be one of the characteristics of the tumor and an important epigenetic modification in the genome, which associates with many of the malignant transformation of cells, tumor invasion and metastasis. The change of local gene methylation patterns has become a remarkable research field. This paper reviews the progress of DNA methylation and tumor gene promoter methylation.
出处 《分子诊断与治疗杂志》 2013年第4期274-278,共5页 Journal of Molecular Diagnostics and Therapy
关键词 DNA甲基化 甲基转移酶 表皮生长因子受体 启动子 DNA methylation DNA methyltransferase Epidermal growth factor receptor Promotor
  • 相关文献

参考文献28

  • 1Christman J K. 5-Azacytidine and 5-aza-2'-deoxycytidine as inhibitors of DNA methylation: mechanistic studies and their implications for cancer therapy[J]. Oncogene, 2002, 21(35): 5483-5495.
  • 2Jones P A, Takai D. The role of DNA methylation in mammalian epigenetics[J]. Science, 2001, 293(5532): 1068-1070.
  • 3Thomson J P, Skene P J, Selfridge J, et al. CpG islands influence chromatin structure via the CpG-binding protein Cfpl[J]. Nature, 2010, 464(7291): 1082-1086.
  • 4苏玉,王溪,朱卫国.DNA甲基转移酶的表达调控及主要生物学功能[J].遗传,2009,31(11):1087-1093. 被引量:41
  • 5Trowbridge J J, Snow J W, Kim J, et al. DNA methyltransferase 1 is essential for and uniquelyregulates hematopoietic stem and progenitor cells[J]. Cell Stem Cell, 2009, 5(4): 442-449.
  • 6Cheng X, Blumenthal R M. Mammalian DNA methyltransferases: a structural perspective[J]. Structure, 2008, 16(3): 341-350.
  • 7Karagianni P, Amazit L, Qin J, et al. ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation[J]. Mol Cell Biol, 2008, 28(2): 705-717.
  • 8Bogdanovi6 O, Veenstra G J. DNA methylation and methyl- CpG binding proteins: developmental requirements and function[J]. Chromosoma, 2009, 118(5): 549-565.
  • 9Clouaire T, Stancheva I. Methyl-CpG binding proteins specialized transcriptional repressors or structural compo 65(10): nents of chromatin[J]. Cell Mol Life Sci, 2008, 1509-1522.
  • 10Shock L S, Thakkar P V, Peterson E J, et al. DNA methyltransferase 1, cytosine methylation, and cytosine hydroxymethylation in mammalian mitochondria[J]. Proc Natl Acad Sci U S A, 2011, 108(9): 3630-3635.

二级参考文献103

  • 1韩颖,罗建民,贾晓辉,王福旭,姚丽,杜行严.白血病患者造血细胞磷酸酶与半胱氨酸蛋白酶基因表达及其临床意义[J].中华内科杂志,2006,45(5):363-365. 被引量:18
  • 2林福安,叶宝国,沈建箴,周华蓉,傅海英,范丽萍.半巢式甲基化特异性聚合酶链反应对肿瘤细胞株p15基因甲基化或缺失状态的检测[J].中国实验血液学杂志,2007,15(2):382-386. 被引量:12
  • 3Cheng X, Blumenthal RM. Mammalian DNA methyltransferases: a structural perspective. Structure, 2008, 16(3): 341-350.
  • 4Hermann A, Gowher H, Jeltsch A. Biochemistry and biology of mammalian DNA methyltransferases. Cell 111101 Life Sci, 2004, 61(19-20): 2571-2587.
  • 5Bestor T, Laudano A, Mattaliano R, Ingram V. Cloning and sequencing of a cDNA encoding DNA methyltransferase of mouse cells. The carboxyl- terminal domain of the mammalian enzymes is related to bacterial restriction methyltransferases. J Mol Biol, 1988, 203(4): 971-983.
  • 6Araujo FD, Croteau S, Slack AD, Milutinovic S, Bigey P, Price GB, Zannis-Hadjopoulos M, Szyf M. The DNMT1 target recognition domain resides in the N terminus. J Biol Chem, 2001, 276(10): 6930-6936.
  • 7Pradhan M, Esteve PO, Chin HG, Samaranayke M, Kim GD, Pradhan S. CXXC domain of human DNMT1 is essential for enzymatic activity. Biochemistry, 2008, 47(38): 10000-10009.
  • 8Fatemi M, Hermann A, Pradhan S, Jeltsch A. The activity of the murine DNA methyltransferase Dnmtl is controlled by interaction of the catalytic domain with the N-terminal part of the enzyme leading to an allosteric activation of the enzyme after binding to methylated DNA. J Mol Biol, 2001, 309(5): 1189-1199.
  • 9Goyal R, Rathert P, Laser H, Gowher H, Jeltsch A. Phosphorylation of serine-515 activates the Mammalian maintenance methyltransferase Dnmt1. Epigeneties, 2007, 2(3): 155-160.
  • 10Karagianni P, Amazit L, Qin J, Wong J. ICBP90, a novel methyl K9 H3 binding protein linking protein ubiquitination with heterochromatin formation. Mol Cell Biol, 2008, 28(2): 705-717.

共引文献59

同被引文献25

  • 1Wakelee H,Kernstine K,Vokes E,et al.Cooperative group research efforts in lung Cancer 2008:focus on advancedstage non small cell lung cancer. Clin Lung Cancer 2008,9(6):346-51.
  • 2Smith. LT,Lin M,Brena 1KM,et al. Epigenetic regulation of the tumor suppressor gene TCF21 on 6q23 q24 in lung and head and neck cancer. Proc Natl Acad Sci,2006,103(4):982-987.
  • 3Banm B,Settleman J,Quinlan MP.Transitions between epithelial and mesenchymal states in development and disease.Semin Cell DevBiol, 2008, 19:294-308.
  • 4Arab K,Smith LT,Gast A,et al.Epigenetic deregulation of TC1:21 inhibits metastasis suppressor KISS-1 in metastatic melanoma.Carcinog enesis,2011,32(10):1467-1473.
  • 5Arab K,Smith LT,Gast A,et al.Epigenetic deregulation of TCF21 inhibits metastasis suppressor KISS-1 in metastatic melanoma.Carcinogenesis, 2011,32(10) : 1467-1473.
  • 6Lee JH,Miele ME,Hicks DJ,et al.Kiss-l,a novel human malignant melanoma metastasis suppressor genelJ Natl Cancer Inst,1996,88(23): 1731-1737.
  • 7Shivapurkar N,Stasmy V,Xie Y,et al.Differential methylation of ashort CpG-rich sequence within exon 1 of TCF21 gene:a promising cancer biomarker assay.Cancer Epidemiol Biomarkers Prey, 2008, 17: 995-1000.
  • 8Tessema M,Willink R,Do K,et al.Promoter methylation of genes in and around the candidate lung cancer susceptibility locus 6q2325. Cancer Res,2008,68:1707-1714.
  • 9P, iehards KL,Zhang B,Sun M,et al.Methylation of the candidate biomarker TCF2 1 is very fi'equent across a spectrum of early-stage nonsmall cell lung cancers.Cancer,2011,117:606-617.
  • 10Tessema M,Belinsky SA.Mining the epigenome for methylated genes in lung cancer.Proc Am Thorac Soc,2008,5:806-810.

引证文献2

二级引证文献2

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部